101 related articles for article (PubMed ID: 21646742)
1. Serum C-reactive protein levels and death and cardiovascular events in mild to moderate chronic kidney disease.
Koeda Y; Nakamura M; Tanaka F; Onoda T; Itai K; Tanno K; Ohsawa M; Makita S; Ishibashi Y; Koyama T; Yoshida Y; Omama S; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
Int Heart J; 2011; 52(3):180-4. PubMed ID: 21646742
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
[TBL] [Abstract][Full Text] [Related]
3. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
4. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
Skali H; Uno H; Levey AS; Inker LA; Pfeffer MA; Solomon SD
Am Heart J; 2011 Sep; 162(3):548-54. PubMed ID: 21884875
[TBL] [Abstract][Full Text] [Related]
5. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
6. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
7. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.
Rogacev KS; Pickering JW; Seiler S; Zawada AM; Emrich I; Fliser D; Heine GH
Nephrol Dial Transplant; 2014 Feb; 29(2):348-55. PubMed ID: 24166454
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease: A population-based study in Taiwan.
Tsai YW; Chan YL; Chen YC; Cheng YH; Chang SS
Medicine (Baltimore); 2018 Sep; 97(36):e11896. PubMed ID: 30200074
[TBL] [Abstract][Full Text] [Related]
10. Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.
Palau V; Riera M; Duran X; Valdivielso JM; Betriu A; Fernández E; Pascual J; Soler MJ
Nephrol Dial Transplant; 2020 Jan; 35(1):130-138. PubMed ID: 30102333
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and prognosis in elderly patients with cardiovascular disease: Comparison between CKD-EPI and Berlin Initiative Study-1 formulas.
Tarantini L; McAlister FA; Barbati G; Ezekowitz JA; Cioffi G; Faggiano P; Pulignano G; Cherubini A; Grisolia Franceschini E; Di Lenarda A
Eur J Prev Cardiol; 2016 Sep; 23(14):1504-13. PubMed ID: 26988974
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
13. Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population.
Sakuma M; Nakamura M; Tanaka F; Onoda T; Itai K; Tanno K; Ohsawa M; Sakata K; Yoshida Y; Kawamura K; Makita S; Okayama A
Circ J; 2010 Apr; 74(4):792-7. PubMed ID: 20160392
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease.
Tarantini L; Barbati G; Cioffi G; McAlister FA; Ezekowitz JA; Mazzone C; Faganello G; Russo G; Franceschini Grisolia E; Di Lenarda A
Intern Emerg Med; 2015 Dec; 10(8):955-63. PubMed ID: 26123617
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid independently predicts cardiovascular events in advanced nephropathy.
Kanbay M; Yilmaz MI; Sonmez A; Solak Y; Saglam M; Cakir E; Unal HU; Arslan E; Verim S; Madero M; Caglar K; Oguz Y; McFann K; Johnson RJ
Am J Nephrol; 2012; 36(4):324-31. PubMed ID: 23007099
[TBL] [Abstract][Full Text] [Related]
16. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
[TBL] [Abstract][Full Text] [Related]
17. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
Klarin D; Lancaster RT; Ergul E; Bertges D; Goodney P; Schermerhorn ML; Cambria RP; Patel VI;
J Vasc Surg; 2016 Nov; 64(5):1295-1302. PubMed ID: 27776697
[TBL] [Abstract][Full Text] [Related]
18. Renal scintigraphy predicts global cardiovascular risk in hypertensive subjects with normal serum creatinine levels.
Mazza A; Rampin L; Montemurro D; Schiavon L; Zuin M; Grassetto G; Chondrogiannis S; Al-Nahhas A; Ramazzina E; Rubello D
Blood Press; 2011 Dec; 20(6):387-93. PubMed ID: 22017389
[TBL] [Abstract][Full Text] [Related]
19. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
20. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease.
Roumeliotis A; Roumeliotis S; Panagoutsos S; Theodoridis M; Argyriou C; Tavridou A; Georgiadis GS
Ren Fail; 2019 Nov; 41(1):131-138. PubMed ID: 30909780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
